CDK2 and cancer: Nevertheless, acute pharmacological or peptide-based inhibition of CDK2 strongly inhibits cancer cell proliferation22–25, CDK2 counteracts Myc-induced cellular senescence26 and CDK2-knockout mouse cells are resistant to oncogenic transformation19.